XML 51 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Stockholders' Equity (Deficit) (USD $)
In Thousands, except Share data
Total
Series A Preferred Stock
Series B Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2009 $ (6,348)       $ 17 $ 74,288 $ (96) $ (80,557)
Balances Beginning, Shares at Dec. 31, 2009   3 1 16,659      
Employee stock option and warrant compensation expense 2,262          2,262      
Amortization of fair value of stock issued to related parties for purchase of Neonode Technologies AB (formerly AB Cypressen) 3,168          3,168      
Reclassification of derivative liabilities to additional paid-in capital 19,286          19,286      
Common stock issued to settle lawsuit 647          647      
Common stock issued to settle lawsuit, shares         498      
Exchange of Series A Preferred Stock for common stock          2 (2)      
Exchange of Series A Preferred Stock for common stock, shares   (3)    1,577      
Exchange of Series B Preferred Stock for common stock                     
Exchange of Series B Preferred Stock for common stock, shares      (1) 73      
Proceeds for issuance of warrants 49          49      
Common stock issued upon conversion of debt including beneficial conversion feature amounts 179          179      
Common stock issued upon conversion of debt including beneficial conversion feature amounts, shares         186      
Common stock issued to brokers 65          65      
Common stock issued to brokers, shares         57      
Common stock issued to investors in the 2010 warrant repricing financing transaction 2,421       3 2,418      
Common stock issued to investors in the 2010 warrant repricing financing transaction, shares         2,767      
Foreign currency translation adjustment 33             33   
Net loss (31,626)           (31,626)
Balance at Dec. 31, 2010 (9,864)       22 102,360 (63) (112,183)
Balances, shares at Dec. 31, 2010         21,817      
Employee stock option and warrant compensation expense 550          550      
Common stock issued upon exercise of warrants 515       1 514      
Common stock issued upon exercise of warrants, Shares         543      
Proceeds from sale of common stock, net of offering costs 10,787       3 10,784      
Proceeds from sale of common stock, net of offering costs, Shares         3,000      
Reclassification of derivative liabilities to additional paid-in capital 20,075          20,075      
Fair value of warrants issued in connection with issuance of 2011 Senior Secured Convertible Debt 937          937      
Exchange of Series A Preferred Stock for common stock                     
Exchange of Series A Preferred Stock for common stock, shares         40      
Exchange of Series B Preferred Stock for common stock                     
Exchange of Series B Preferred Stock for common stock, shares         6      
Common stock issued upon conversion of outstanding convertible debt and accrued and bonus income 7,622       7 7,615      
Common stock issued upon conversion of outstanding convertible debt and accrued and bonus income, shares         7,313      
Common stock issued for settlement of accrued expenses 120          120      
Common stock issued for settlement of accrued expenses, shares         60      
Foreign currency translation adjustment 76             76   
Net loss (17,145)           (17,145)
Balance at Dec. 31, 2011 13,673       33 142,955 13 (129,328)
Balances, shares at Dec. 31, 2011         32,779      
Employee stock option and warrant compensation expense 3,499          3,499      
Common stock issued upon exercise of warrants 223          223      
Common stock issued upon exercise of warrants, Shares         550      
Exchange of Series B Preferred Stock for common stock                     
Exchange of Series B Preferred Stock for common stock, shares         2      
Foreign currency translation adjustment (8)             (8)   
Net loss (9,287)           (9,287)
Balance at Dec. 31, 2012 $ 8,100       $ 33 $ 146,677 $ 5 $ (138,615)
Balances, shares at Dec. 31, 2012         33,331